Added to YB: 2019-04-09
Pitch date: 2019-04-09
ZGNX:US [bullish]
Zogenix, Inc.
-33.22%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Zogenix, Inc., a biopharmaceutical company, develops and commercializes therapies to transform the lives of patients and their families living with rare diseases in the United States and Europe.
Market Cap
$1.5B
Pitch Price
$39.95
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
-6.56
EV/Sales
N/A
Sector
Pharmaceuticals
Category
N/A
Show full summary:
ZOGENIX INC ZGNX:US
A summary for this pitch has not been created yet.
Read full article (0 min)